无插管ECMO作为肺移植桥接的应用与结局
基于UNOS数据库2005年至2023年1599例成人肺移植受者,比较ECMO联合机械通气与单纯ECMO桥接的结局。单纯ECMO组72小时插管率更低、住院时间更短、90天生存率更高,但1年和5年生存率无差异。
要点
- 无插管ECMO桥接肺移植与更优的围术期结局和短期生存相关。
- 单纯ECMO组72小时插管率56.5% vs 77.5%,调整OR 0.33。
- 两组1年及5年生存率无显著差异。
核心结论
- 无插管ECMO桥接肺移植与改善的围术期结局和短期生存相关,应考虑用于需要ECMO的候选者。
研究设计与样本
- 回顾性队列研究,基于UNOS数据库2005年5月4日至2023年3月8日成人单纯肺移植受者,共1599例,分为ECMO+MV组(902例,56.4%)和ECMO-only组(697例,43.6%)。
主要发现
- ECMO-only组中位年龄更高(52 vs 49岁,p<0.001),缺血时间更短(5.7 vs 6.0小时,p=0.003),肺分配评分相似(89.5 vs 89.6,p=0.11)。
- ECMO-only组72小时插管率更低(56.5% vs 77.5%;调整OR 0.33 [95%CI: 0.25, 0.42],p<0.001)。
- ECMO-only组住院时间更短(28 vs 35天;系数-0.19 [95%CI: -0.27, -0.11],p<0.001)。
- ECMO-only组90天生存率更高(92.1% vs 89.1%;调整HR 0.69 [95%CI: 0.48, 0.99],p=0.04)。
- 两组1年生存率(83.1% vs 81.5%;调整HR 0.87 [95%CI: 0.67, 1.12],p=0.27)和5年生存率(54.6% vs 54.7%;调整HR 0.98 [95%CI: 0.82, 1.17],p=0.83)无显著差异。
临床怎么用
- 对于需要ECMO桥接的肺移植候选者,可考虑采用无插管ECMO策略以改善围术期结局和短期生存。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Nonintubated extracorporeal membrane oxygenation (ECMO) has been increasingly utilized for patients with severe respiratory failure. Since data on its use as a bridge to lung transplant remain limited, we evaluated its use in a national cohort. METHODS: Adult lung-only transplant recipients bridged with ECMO May 4, 2005 to March 8, 2023 in the United Network for Organ Sharing database were categorized by use of ECMO and mechanical ventilation (MV) at transplant (ECMO+MV vs ECMO-only). We compared post-transplant intubation and ECMO at 72 hours, length of stay, and survival. RESULTS: The 1,599 transplants identified included 902 (56.4%) bridged with ECMO+MV and 697 (43.6%) bridged with ECMO-only. ECMO-only recipients had higher median age (52 vs 49 years, p < 0.001), shorter ischemic times (5.7 vs 6.0 hours, p = 0.003), and similar lung allocation scores (89.5 vs 89.6, p = 0.11). ECMO-only recipients had lower likelihood of intubation at 72 hours (56.5% vs 77.5%; adjusted odds ratio 0.33 [95% confidence interval (CI): 0.25, 0.42], p < 0.001) and shorter lengths of stay (28 vs 35 days; coefficient -0.19 [95% CI: -0.27, -0.11], p < 0.001). ECMO-only recipients had higher 90-day survival (92.1% vs 89.1%; adjusted hazards ratio (aHR) 0.69 [95% CI: 0.48, 0.99], p = 0.04) but similar 1-year (83.1% vs 81.5%; aHR 0.87 [95% CI: 0.67, 1.12], p = 0.27) and 5-year (54.6% vs 54.7%; aHR 0.98 [95% CI: 0.82, 1.17], p = 0.83) survival. CONCLUSIONS: Nonintubated ECMO bridge to lung transplant was associated with improved perioperative outcomes and short-term survival and should be considered for candidates requiring ECMO.
引用
- Zhou AL, Jennings MR, Akbar AF, et al. Utilization and outcomes of nonintubated extracorporeal membrane oxygenation as a bridge to lung transplant. J Heart Lung Transplant. 2024. PMID: 39486773. doi:10.1016/j.healun.2024.10.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。